- Home
- AON vs GSK Comparison
AON vs GSK Comparison
Compare AON & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AON
- GSK
- Stock Information
- Founded
- AON 1919
- GSK 1715
- Country
- AON Ireland
- GSK United Kingdom
- Employees
- AON N/A
- GSK N/A
- Industry
- AON Specialty Insurers
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- AON Finance
- GSK Health Care
- Exchange
- AON Nasdaq
- GSK Nasdaq
- Market Cap
- AON 81.3B
- GSK 71.7B
- IPO Year
- AON N/A
- GSK N/A
- Fundamental
- Price
- AON $354.73
- GSK $36.87
- Analyst Decision
- AON Hold
- GSK Hold
- Analyst Count
- AON 14
- GSK 4
- Target Price
- AON $382.00
- GSK $47.00
- AVG Volume (30 Days)
- AON 1.7M
- GSK 5.7M
- Earning Date
- AON 04-25-2025
- GSK 04-30-2025
- Dividend Yield
- AON 0.83%
- GSK 4.33%
- EPS Growth
- AON N/A
- GSK N/A
- EPS
- AON 11.75
- GSK 0.98
- Revenue
- AON $16,357,000,000.00
- GSK $40,735,668,430.00
- Revenue This Year
- AON $11.60
- GSK $7.19
- Revenue Next Year
- AON $6.32
- GSK $5.34
- P/E Ratio
- AON $30.40
- GSK $18.10
- Revenue Growth
- AON 20.49
- GSK 2.57
- 52 Week Low
- AON $275.07
- GSK $31.72
- 52 Week High
- AON $412.97
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- AON 44.58
- GSK 47.28
- Support Level
- AON $351.68
- GSK $36.42
- Resistance Level
- AON $363.61
- GSK $39.23
- Average True Range (ATR)
- AON 8.15
- GSK 0.74
- MACD
- AON 1.33
- GSK -0.05
- Stochastic Oscillator
- AON 70.46
- GSK 22.67
About AON Aon plc (Ireland)
Aon is a leading global provider of insurance and reinsurance brokerage and human resources solutions. Its operations are tilted toward its brokerage operations. Headquartered in London, Aon has about 50,000 employees and operations in over 120 countries.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.